Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)
NCT01699165 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2013-04-19
Summary
The purpose of this study is to assess the effect of reducing exposure to allergens in patients with hay fever by means of a nasal filter.
Conditions
- Rhinitis, Allergic, Seasonal
Interventions
- DEVICE
-
Nasal filter
Active nasal filter
- DEVICE
-
Placebo nasal filter
Placebo nasal filter
Sponsors & Collaborators
-
Spirare ApS
collaborator UNKNOWN -
University of Aarhus
lead OTHER
Principal Investigators
-
Torben Sigsgaard, Professor · Aarhus University, School of Public Health, Dept. of Environmental & Occupational Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- Denmark
Study Locations
More Related Trials
-
Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
NCT00305487 ·Status: COMPLETED ·Phase: PHASE3
-
Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever
NCT00135629 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
NCT01451541 ·Status: COMPLETED ·Phase: PHASE3
-
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
NCT05191186 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season
NCT00474890 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
NCT01010971 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
NCT01033396 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis
NCT03157505 ·Status: COMPLETED ·Phase: PHASE3
-
A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment
NCT05560698 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
NCT00790023 ·Status: COMPLETED ·Phase: PHASE3
-
Repeat Nasal Allergen Challenge
NCT00290368 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)
NCT06920771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
House Dust Mite Injection Immunotherapy in Elderly Patients.
NCT03209245 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies
NCT00719862 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis
NCT01484119 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy & Safety of the UAS Immunotherapy Protocol
NCT01699659 ·Status: COMPLETED
-
Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
NCT00263549 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
NCT00561717 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis
NCT01916226 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
NCT00163514 ·Status: COMPLETED ·Phase: PHASE3
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study
NCT06778213 ·Status: RECRUITING ·Phase: PHASE4
-
Mechanisms of Allergen Immunotherapy
NCT00001910 ·Status: COMPLETED
-
Safety and Efficacy Study of rEV131 in Allergic Rhinitis
NCT00247520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2